Immuno-oncology market set to grow in billions, but access concerns remain
Pharmaceutical Technology
MAY 26, 2023
The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar. Market access was also a key point of focus.
Let's personalize your content